US FDA puts Gilead Sciences blood cancer drug studies on hold
(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...
(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...
By Allison Lampert and Doyinsola Oladipo (Reuters) -Canadians vented their frustration against airlines on social...
A look at the day ahead in U.S. and global markets from Mike Dolan There’s...
BEIJING (Reuters) -China’s fiscal revenue rose 11.5% in the first seven months of 2023 from...
By David Randall NEW YORK (Reuters) -Several indicators that pointed to upside for U.S. stocks...
By Ju-min Park SEOUL (Reuters) – Suspected North Korean hackers have targeted a joint U.S.-South...
(Reuters) – Social media company X, formerly known as Twitter, will remove a protective feature...
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its...
By Medha Singh (Reuters) -VinFast shares slumped for a third straight session on Friday, with...
By Nichola Groom (Reuters) -The United States on Friday finalized a decision to impose import...